Welcome to LookChem.com Sign In|Join Free

Products

  • or
Home > Products > 1622 > 

1622-62-4

Refine

Refine

Country

Business Type

Certificate

Display

Products Categories

Basic Information
CAS No.: 1622-62-4
Name: FLUNITRAZEPAM
Molecular Structure:
Molecular Structure of 1622-62-4 (FLUNITRAZEPAM)
Formula: C16H12FN3O3
Molecular Weight: 313.288
Synonyms: 2H-1,4-Benzodiazepin-2-one,5-(o-fluorophenyl)-1,3-dihydro-1-methyl-7-nitro- (7CI,8CI);5-(2-Fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one;5-(2-Fluorophenyl)-1-methyl-7-nitro-1,3-dihydrobenzo[e][1,4]diazepin-2-one;5-(o-Fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one;7-Nitro-1-methyl-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2(1H)-one;Flunidazepam;Flunipam;Flunitrazepam;Fluridrazepam;Narcozep;Ro 5-4200;Rohypnol;Roipnol;Silece;
EINECS: 216-597-8
Density: 1.39g/cm3
Melting Point: 166-167 °C
Boiling Point: 540.9°Cat760mmHg
Flash Point: 280.9°C
Solubility: 45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin: 1 mg/mL
Appearance: UN 1230 3/PG 2
Hazard Symbols: HarmfulXnToxicTFlammableF
Risk Codes: 22-36-39/23/24/25-23/24/25-11
Safety: Moderately toxic by ingestion and intraperitoneal routes. An experimental teratogen. Human reproductive effects by ingestion and intramuscular routes: Apgar score of newborn and other neonatal and postnatal effects. Experimental reproductive effects. Mutation data reported. Human systemic effects by ingestion: coma. Used as a hypnotic agent. Note: This is a controlled substance (depressant) listed in the U.S. Code of Federal Regulations, Title 21 Part 1308.14 (1985). When heated to decomposition it emits toxic fumes of F and NOx.
PSA: 78.49000
LogP: 2.57150
  • Display:default sort

    New supplier

This product is a nationally controlled contraband, and the Lookchem platform doesn't provide relevant sales information.

Chemistry

Molecular Structure of Flunitrazepam (CAS NO.1622-62-4):

IUPAC Name: 5-(2-Fluorophenyl)-1-methyl-7-nitro-3H-1,4-benzodiazepin-2-one
Empirical Formula: C16H12FN3O3
Molecular Weight: 313.2832 
EINECS: 216-597-8 
Storage temp.: 2-8°C
Solubility: 45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin: 1 mg/mL 
Index of Refraction: 1.648
Molar Refractivity: 81.84 cm3
Molar Volume: 224.8 cm3
Surface Tension: 52.5 dyne/cm
Density: 1.39 g/cm3
Flash Point: 280.9 °C
Enthalpy of Vaporization: 81.87 kJ/mol
Boiling Point: 540.9 °C at 760 mmHg
Vapour Pressure: 9.13E-12 mmHg at 25 °C
Melting Point: 166-167 °C
Water Solubility: 72.8 mg/L at 25 °C
Classification Code: Anti-Anxiety Agents; Central Nervous System Agents; Central Nervous System Depressants; Drug / Therapeutic Agent; GABA Agents; GABA modulators; Human Data; Mutation data; Neurotransmitter Agents; Psychotropic Drugs; Reproductive Effect; Sedative-hypnotic; Tranquilizing Agents 

Uses

Just as with other hypnotics, Flunitrazepam should only be used on a short-term basis or in those with chronic insomnia on an occasional basis.

Toxicity Data With Reference

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
child TDLo oral 3478ug/kg (3.478mg/kg) BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY)

BEHAVIORAL: COMA

VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION
Critical Care Medicine. Vol. 17, Pg. 1355, 1989.
human LDLo oral 430ug/kg (0.43mg/kg)   Journal of Analytical Toxicology. Vol. 11, Pg. 278, 1987.
human TDLo oral 184ug/kg (0.184mg/kg) BEHAVIORAL: COMA Journal of Analytical Toxicology. Vol. 11, Pg. 278, 1987.
infant TDLo oral 222ug/kg (0.222mg/kg) SENSE ORGANS AND SPECIAL SENSES: MIOSIS (PUPILLARY CONSTRICTION): EYE

BEHAVIORAL: GENERAL ANESTHETIC

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 38, Pg. 2597, 1996.
mouse LD50 intramuscular > 2gm/kg (2000mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: TREMOR
Kiso to Rinsho. Clinical Report. Vol. 19, Pg. 1277, 1985.
mouse LD50 intraperitoneal 1050mg/kg (1050mg/kg) SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
Kiso to Rinsho. Clinical Report. Vol. 19, Pg. 1277, 1985.
mouse LD50 oral 1200mg/kg (1200mg/kg) SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
Kiso to Rinsho. Clinical Report. Vol. 19, Pg. 1277, 1985.
mouse LD50 subcutaneous > 4gm/kg (4000mg/kg)   Kiso to Rinsho. Clinical Report. Vol. 19, Pg. 1277, 1985.
rat LD50 intramuscular > 2gm/kg (2000mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: TREMOR
Kiso to Rinsho. Clinical Report. Vol. 19, Pg. 1277, 1985.
rat LD50 intraperitoneal 1060mg/kg (1060mg/kg) SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Kiso to Rinsho. Clinical Report. Vol. 19, Pg. 1277, 1985.
rat LD50 oral 415mg/kg (415mg/kg) SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
Kiso to Rinsho. Clinical Report. Vol. 19, Pg. 1277, 1985.
rat LD50 subcutaneous > 4gm/kg (4000mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: TREMOR

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Kiso to Rinsho. Clinical Report. Vol. 19, Pg. 1277, 1985.
women TDLo oral 127ug/kg (0.127mg/kg) BEHAVIORAL: COMA Archives of Internal Medicine. Vol. 145, Pg. 663, 1985.

Safety Profile

Moderately toxic by ingestion and intraperitoneal routes. An experimental teratogen. Human reproductive effects by ingestion and intramuscular routes: Apgar score of newborn and other neonatal and postnatal effects. Experimental reproductive effects. Mutation data reported. Human systemic effects by ingestion: coma. Used as a hypnotic agent. Note: This is a controlled substance (depressant) listed in the U.S. Code of Federal Regulations, Title 21 Part 1308.14 (1985). When heated to decomposition it emits toxic fumes of F and NOx.
Safety Information of Flunitrazepam (CAS NO.1622-62-4):
Hazard Codes: HarmfulXn,ToxicT,FlammableF
Risk Statements: 22-36-39/23/24/25-23/24/25-11 
R22:Harmful if swallowed. 
R36:Irritating to eyes. 
R39:Danger of very serious irreversible effects. 
R23/24/25:Toxic by inhalation, in contact with skin and if swallowed. 
R11:Highly flammable.
Safety Statements: 7-16-36/37-45-36-26 
S7:Keep container tightly closed. 
S16:Keep away from sources of ignition. 
S36/37:Wear suitable protective clothing and gloves. 
S36:Wear suitable protective clothing. 
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. 
S45:In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
RIDADR: UN 1230 3/PG 2
WGK Germany: 2
RTECS: DF2385000
HazardClass: 6.1(b)
PackingGroup: III

Specification

  Flunitrazepam (CAS NO.1622-62-4), its Synonyms are 1,3-Dihydro-5-(o-fluorophenyl)-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one ; 1-Methyl-7-nitro-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2(1H)-one ; 5-(o-Fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one ; Flunitrazepamum ; Narcozep ; Primun ; Ro 5-4200 ; Rohypnol ; 2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-5-(2-fluorophenyl)-1-methyl-7-nitro- ; 2H-1,4-Benzodiazepin-2-one, 5-(2-fluorophenyl)-1,3-dihydro-1-methyl-7-nitro- .